𝔖 Bobbio Scriptorium
✦   LIBER   ✦

FOLFOX4 in the treatment of metastatic colorectal cancer in elderly patients: A prospective study

✍ Scribed by Massimiliano Berretta; Alessandro Cappellani; Francesco Fiorica; Guglielmo Nasti; Sergio Frustaci; Rossella Fisichella; Alessandra Bearz; Renato Talamini; Arben Lleshi; Rosa Tambaro; Alessandro Cocciolo; Maurizio Ristagno; Antonio Bolognese; Francesco Basile; Nereo Meneguzzo; Salvatore Berretta; Umberto Tirelli

Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
148 KB
Volume
52
Category
Article
ISSN
0167-4943

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A prospective study of pancreatic cancer
A prospective study of pancreatic cancer in the elderly
✍ Atsuko Shibata; Thomas M. Mack; Annlia Paganini-Hill; Ronald K. Ross; Brian E. H πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 French βš– 427 KB

## Abstract Risk factors for pancreatic cancer were examined in a cohort study of 13,979 residents of a retirement community. After 9 years of follow‐up, 65 incident cases of pancreatic cancer were identified. An increased risk of pancreatic cancer was associated with a history of diabetes and chol

FOLFOX in patients aged between 76 and 8
FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer : An exploratory cohort of the OPTIMOX1 study
✍ AriΓ© Figer; Nathalie Perez-Staub; Elisabeth Carola; Christophe Tournigand; Gerar πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 111 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Patients older than 75 years of age are usually excluded from metastatic colorectal cancer randomized studies. The OPTIMOX1 study evaluated FOLFOX7, a simplified (s) leucovorin (LV) and 5‐fluorouracil (5FU) regimen (sLV5FU2) with high‐dose oxaliplatin, in a new oxaliplat